TPOXX
Chemical Name | tecovirimat |
Dosage Form | Capsule (oral; 200 mg) |
Drug Class | Antivirals |
System | Skin, Blood, Respiratory |
Company | Siga Technologies |
Approval Year | 2018 |
Indication
- TPOXX is indicated for the treatment of human smallpox disease in adults and pediatric patients weighing at least 13 kg.